Ann: Significant Sales of DonorCare Needle Guard 2 - ITL Limited, page-5

Agree. In a sector known for tough regulatory oversight, this company has created its own niche and is a long term value proposition. The power of an agile executive team producing really, really smart solutions for a global audience is worthy of praise. Innovation prizes aside, the value of the IP portfolio alone is worth accumulating on the dips. They've been listed in the Microcap Trader portfolio for some time now.